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ABSTRACT
Synthesis of Chemical Models of Hydrolase Enzymes for Intramolecular Catalysis
by
Cornelius N. Ndi
Most nuclease enzymes can hydrolyze phosphoester bonds (in DNA and RNA) by
using metal ions cofactors that coordinate and activate water molecules in the
enzymes’ active sites. However, there are some hydrolase enzymes (including
nucleases) that can function without the aid of metal ions. 2,6-Di(1H-imidazol-2yl)phenol, a model compound for hydrolase enzyme, was synthesized by the
reaction between ethylenediamine and dimethyl-3-carboxysalicylate, initially
resulting in the formation of diimidazoline. The diimidazoline was subsequently
aromatized to the diimidazole by dehydrogenation over palladium. The overall
reaction yield was low; therefore, other dehydrogenation transformation reactions
were tried but all failed to improve the yield. Converting this diimidazolphenol
into diimidazolphenyl monophoshpate derivative was attempted but failed to give
desired products.
Synthesis of 2,2'-anthracene-1,8-diylbis-1H-imidazole, another model compound
for hydrolase enzymes, was attempted using dimethyl –1,8 –
anthracenedicarboxylate, but synthesis was unsuccessful due to solubility problem.
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CHAPTER 1
INTRODUCTION
Phosphate esters are common in nature. They exist in living organisms as
DNA and RNA and are encountered in the environment as insecticides and
pesticides. These esters are known to be very stable; DNA and RNA have halflives of several hundreds of years. The key for successful hydrolysis of
phosphodiester bonds is the delivery of a primary nucleophile at the reaction center
(phosphorus atom).1 Although most hydrolytic enzymes use metal ion cofactors, a
few enzymes are known to do so without metal ions. Such enzymes and their
model compounds have attracted increasing interest in the recent years due to their
potential applications in pharmaceutical industry.
Intramolecular Catalysis
The acceleration of chemical transformation at one site of a molecular
species through the involvement of a neighboring functional (catalytic) group in
the same molecule has been reported in literature, using enzymes as well as model
compounds2. The use of the term autocatalysis (intramolecular catalysis) is
restricted to chemical systems where the substrate and the catalyst are in the same
compound.
Intramolecular catalysis, where the substrate and catalytic group are brought
close together by specific spacers has the following advantages:
12

1.

Increasing the effective concentration of substrate and catalytic

group.
2.

Enhancing the catalytic reaction rate due to the optimal

molecular geometry that results in favorable interaction between the
substrate and the catalytic site. Two to three orders of magnitude of
rate enhancements have been observed in model compounds.
3.

Although less effective than enzymes (with rate enhancements

of five to nine orders of magnitude), these model compounds help
understand mechanism of action of enzymes.
Enzymes
Enzymes are biological catalysts and are required by most metabolic
reactions to occur at required rates. Each cell contains over 500 different enzymes
to enable it to function properly. The type of enzyme required depends on the
nature and function of the cell in the living organism. Over 2000 different
enzymes are known and described in variable depths.
As proteins, enzymes have characteristic primary, secondary, and tertiary
structures. Sequences of amino acids linked by peptide bonds form the primary
structure. Only 20 amino acids are known to constitute all types of proteins that
vary in sizes. The secondary and tertiary structures are involved in determining the
three-dimensional nature of the enzyme.
13

Enzymes involved in cellular metabolic reactions often have quaternary
structures as well. This means that these enzymes have more than one polypeptide
subunits that cooperate in their functions. In some metabolic systems, more
complex forms of enzyme organization are observed. An example of this level of
organization is observed in the fatty acid synthetic pathway in plants and bacteria
where seven different enzymes physically associate with each other to catalyze a
series of reactions.3
Enzyme Catalysis
Enzymes, E, are very sensitive to temperature, pH, and solvents. Despite
these disadvantages as proteins, they tend to be more efficient catalysts than
synthetic catalysts which are less sensitive to such factors. As catalysts, they
follow the normal rules for catalysis:
1)

They do not catalyze thermodynamically unfavorable reactions.

2)

They remain unchanged at the end of the reaction.

3)

They do not change the direction of a reaction.

4)

They do not change the equilibrium of a reaction but increase the rate

at which the equilibrium is reached.
Enzymes lower the activation energy of metabolic reactions by forming an
intermediate enzyme-metabolite complex, E – S, with one or more of the
14

metabolites (Figure 1). This complex subsequently breaks down to give product
and enzyme. This process takes place in the most important catalytic region of the
enzyme called the active site. The active site of an enzyme is a small crevice
composed of specific amino acids that are directly involved in catalysis. Some of
these are shown in Table 1.

Figure 1. Energy diagram for a catalyzed versus non-catalyzed reaction4
(adapted)
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Table 1. Examples of amino acids that are usually involved in the active
sites of enzymes3
Amino acid

Side group`

Interaction with substrate

Serine

-OH

Hydrogen bonding

Cysteine

-SH

Hydrogen bonding/disulphide bridging.

Histidine

-Imidazole

Hydrogen bonding/electrostatic

Lysine

-NH3+

Electrostatic

Arginine

-NH3+

Electrostatic

Aspartic acid

-COO-

Electrostatic

Glutamic acid

-COO-

electrostatic

Mechanism of Enzyme Catalysis
Many different mechanisms by which enzymes bring about catalysis are
known. Two such mechanisms are:
1.

General acid-general base mechanism

2.

Nucleophilic mechanism

16

General Acid-General Base mechanism.
A general acid or base is a compound that is weakly ionizable. At
physiological pH, the protonated imidazole group of histidine acts as a general acid
while the free imidazole acts as a general base.
The role of the imidazole groups is exemplified in the active site of
Ribonuclease (RNAse A) 4. This enzyme is a pancreatic enzyme found in
ruminants and is responsible for the breakdown of excess RNA produced in the
stomach by bacteria and other microorganisms.
The hydrolytic mechanism of RNAse A outlined in Figure 2 is a two-step
process that involves the obligatory formation of a cyclic 2’, 3’-phosphoribose
nucleotide intermediate. In the first stage of the mechanism, His 119 protonates
the phosphodiester, and in a concerted manner, His 12 acts as a general base by
abstracting a proton from the ribose-3’-hydroxyl group forming a nucleophile.
This nucleophile attacks the phosphate group forming the cyclic intermediate and
breaking the RNA chain. The cyclic intermediate is broken down in the second
step by a reversal of the first step with water replacing the leaving group. The
histidines are reverted to their original states.

17

Figure 2. Role of Imidazole in the active site of RNAseA4
Nucleophilic Mechanism.
In this mechanism, the attack of a nucleophilic group on the substrate results
in an enzyme-substrate intermediate that is more labile compared to the original
substrate.
Trypsin, chymotrypsin, and thrombin are serine protease enzymes that use
this mechanism. Another good example is the salicylic acid binding protein 2
(SABP2)5 that is responsible for the hydrolysis of methyl salicylate to salicylic acid
during the defense mechanism against pathogens in the tobacco plant. In the above

18

enzymes, a catalytic triad is observed. This triad is made up of the –COO- group of
aspartic acid, the imidazole group of histidine, and the –OH group of serine.
The hydrolysis of a peptide bond by chymotrypsin is initiated by a
nucleophilic attack by the alkoxide nucleophile of the Ser 195 residue. This
nucleophile is formed by hydrogen transfer from the –OH group to the imidazole
group. This transfer is stabilized by the –COO- group (Figure 3). The alkoxide
attack results in the release of the amino terminal of the protein and the formation
of an acylated enzyme. The acylated enzyme is then subsequently broken down by
a reversal of the reaction pathway with water acting as a nucleophile (Figure 3).

Figure 3. Nucleophilic catalysis in active site of chymotrypsin4
19

Previously Studied Models
We have shown so far that at the physiological pH of the body, some groups
have very high catalytic activities and that these groups act as either general acids,
bases, or nucleophiles. Many early scientists have explored the properties of these
catalytic groups to study and shed more light on their mechanism of action.
As early as the 1950s, L. J Edwards studied in great details the hydrolysis of
aspirin. In the last decade, his work has been adapted into a laboratory exercise for
undergraduate students6. In his work, Edwards showed that the mechanism of
hydrolysis of aspirin is pH dependent. The mechanism changes from specific acid
to general base nucleophilic assisted to specific base as the pH was increased. The
general base nucleophilic assisted mechanism occurred between pH of 4.5 and 8.5;
within this range the carboxylic acid group exists in the deprotonated form as
carboxylate.
The kinetics of aspirin hydrolysis was monitored using a UV
spectrophotometer by measuring the absorbance of the product formed at 298 nm;
the isosbestic point of the salicylic acid-salicylate ion pair.6 The observed rate was
consistent with general base nucleophilic assisted mechanism. This mechanism
involved the carboxylate ion deprotonating a water molecule, forming a strong
nucleophile that attacks the ester, bringing about its own hydrolysis (Figure 4).
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Figure 4. General base nucleophilic assisted hydrolysis of aspirin6
In 1968, Fresht and Kirby studied the intramolecular hydrolysis of the nitroderivatives of aspirin7, 8. Unlike the case of aspirin, they observed that the rate of
hydrolysis is independent of pH between 4 and 8. In contrast to the mechanism
proposed earlier by Edwards (Figure 4), a mechanism involving a direct
nucleophilic attack by the carboxylate group on the ester function resulting into an
intermediate anhydride was proposed (Figure 5). The anhydride is subsequently
broken down in a rate determining step by general base mechanism involving an
alkoxide ion. It was observed also that the overall reaction rate was 50 times faster
compared to hydrolysis of aspirin7. This rate enhancement was attributed to the
increased stability of the phenoxide intermediate, which makes a good leaving
group.
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Figure 5. Nucleophilic hydrolysis of 3, 5- dinitroaspirin7
In 1983, Katherine and Kirby studied the hydrolysis of bis-2-carboxyphenyl
phosphate9. Results showed that the hydrolysis was fastest around pH 4.5. At this
pH, the molecule exists in the dianion form. A mechanism involving an initial
nucleophilic attack by the carboxylate group to form a cyclic phosphate ester was
proposed. This nucleophilic attack was followed by a rather inefficient general
acid attack by the –COOH group (Figure 6).
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Figure 6. Hydrolysis of bis-2-carboxyphenyl phosphate9
We have so far looked at some model compounds bearing –COOH groups.
Extensive investigation of imidazole catalysis dates back to 1973. Gary A. Rogers
and Thomas C. Bruice inspired by the participation of an imidazolyl group in the
catalytic action of serine esterases, synthesized and studied model compounds to
investigate the influence of electronic and steric factors on the intramolecular
imidazole catalysis10. Based on their findings, they concluded that three modes of
intramolecular imidazole catalysis of ester hydrolysis can take place: (1) general
acid assisted water attack, (2) general base assisted water attack, and (3) O
acetyl transfer to imidazole anion followed by subsequent hydrolysis.
23

N

Recently, Elisa S. Orth et al. have shown that two imidazole group can assist
in the hydrolysis of phosphodiesters. They found that Bis(2-(1-methyl-1Himidazolyl)phenyl) phosphate (BMIPP) auto catalyzes its own hydrolysis1. Based
on both hydrolysis experiments and computational evidence, they proposed a
concerted intramolecular nucleophilic catalysis and intramolecular general acid
catalysis (path B). Their conclusion was based on the detection of the short-lived
intermediate INT (Scheme 1)

Scheme 1. Mechanism for the rapid hydrolysis of BMIPP1

24

Research Prospective
Our initial research plan was to synthesize and study two model enzyme
systems. Enzyme model compounds in model system 1can recognize the substrate
through π – π stacking. This model system involves either two carboxylic groups
or two imidazole rings anchored on an anthracene ring as a spacer (Scheme 2).
The substrate for this model would be a 9 – anthylphosphate (4). The two
anthracene rings, of both the catalyst and the substrate, would recognize each other
in a highly ordered manner by π – π interactions; such recognition allows both the
catalytic groups and the phosphate ester of the substrate to be brought into close
proximity, thus resulting in hydrolysis of the phosphate ester by general acid –
base mechanism. Model system 2 involves attaching both the phosphate ester
(substrate) and the catalytic groups (either carboxylic groups or imidazole rings) to
the same anthracene spacer (Scheme 2).
Our synthetic approach for 9 – anthylphosphate was modified after facing
synthetic problems. Maintaining the same initial idea of involving anthracene, we
decided to use dimethoxyl-9-anthylphosphate substrate (5).
In related work, we later explored the synthesis of yet a third model system
(model system 3), in which both the catalytic imidazole rings (or the carboxyl
groups) and the phosphate ester substrate are attached to a benzene ring (Scheme
2).
25

Model system1

Substrates (4 and 5) for model compounds 1 through 3.
Model system 2

IM- Imidazole
Model 3

Scheme 2. Target enzyme model compounds planned for this research
26

CHAPTER 2
EXPERIMENTAL
General Method
All commercial reagents were purchased and used without further
purification except where otherwise stated. Organic solvents were distilled prior to
use, over proper drying agents.
Proton (1H) and carbon-13 (13C) (decoupled) NMR spectra were recorded on
JEOL- NMR Eclipse spectrophotometer operating at 400MHz. The chemical shift
values are recorded in parts per million (ppm) relative to TMS. The multiplicity of
signals is recorded as such; singlet (s), doublet (d), triplet (t) and multiplet (m).
Thin layer chromatography (TLC) was carried out using silica gel plates and
viewed under UV. Column chromatography separation of compounds was carried
out using silica gel. Melting points were obtained using Cambridge Mel-Temp
instrument and the values are uncorrected.
Synthesis of 9-Anthranol
Anthrone (3g, 15.3mmol) was dissolved in freshly prepared 10% NaOH
(180mL). The mixture refluxed for 20 mins under nitrogen. Ice (300g) was added
to the mixture followed by conc.H2SO4 (15 mL). Toluene (120mL) was used to
27

extract the organic compound from the aqueous mixture. After washing with water
(200mL), the organic layer was dried over anhydrous Na2SO4. The organic solvent
was then evaporated and the resulting solid (1.02g) was dried under vacuum.
Characterization of the resulting solid by NMR and melting point showed
unreacted starting material. No further attempts to synthesize 9 – anthranol were
made.
Synthesis of Anthracen-9-yl Hydrogen Phosphate
Anthrone (2.55mmol) was mixed with 150mg (2.67mmol) of KOH in 25 mL
of THF. The mixture was refluxed under nitrogen until all solid dissolved.
Phosphorus oxychloride (POCl3) (5.35mmol) was dissolved in ice-cold THF
(10 mL). The anthrone/KOH solution was then added drop wise to the POCl3
solution and left to react for 2 hours. Water (0.5mL) was then added to the mixture
and stirred overnight.
Tetrahydrofuran, THF, was removed under reduced pressure. A mixture of
methanol (5mL) and water (3mL) was added to the resulting solid and left standing
overnight. The resulting solid (0.53g) was then filtered out and dried under
vacuum. Characterization of this solid by melting point and then NMR was
consistent with the structure of anthrone.
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Synthesis of Anthraquinone -1,8-dicarboxylic Acid
1,8 –Dichloroanthraquinone (20g, 72.4 mmol) and cuprous cyanide (20g,
216 mmol) were stirred overnight under reflux in N,N-dimethylacetamide(150mL)
under dry nitrogen gas. The hot solution was poured into a beaker containing 1L
of water with stirring. The copper (I) complex precipitate was filtered and digested
in 150mL of hot 3N HNO3 to afford the 1,8 – anthraquinonedinitrile.
The crude dinitrile was hydrolyzed in 80% H2SO4 acid at 170oC for 4 hours.
The hot solution was slowly poured into ice and the precipitate was filtered,
washed with water, and redissolved in 10% NaOH. The resulting slurry was then
filtered. The filtrate was acidified with 6M HCl to yield crude product. The
product was recrystallized from water to yield fine-brown crystals (16 g, 77%, m.p.
297oC-300oC, lit 305o-311o).
Synthesis of Anthracene-1,8-dicarboxylic Acid (2)
Anthraquinone -1,8-dicarboxylic acid (7.5 g, 25.33mmol) was stirred with
Zn dust and copper (II) sulfate at reflux in 300 mL aqueous ammonia solution
(20%) overnight. The hot amber solution was filtered, cooled, and acidified with
conc. HCl. Crude product was recrystallized from aqueous dioxane to yield
anthracene-1,8-dicarboxylic acid (4 g, 75%, m.p. 2970C-3000C (decomposed)).
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Synthesis of 9-Hydroxylanthracene-1,8-dicarboxylic Acid
Anthraquinone-1, 8-dicarboxylic acid (1 g, 3.62 mmol) was suspended in
glacial acetic acid and freshly prepared solution of SnCl2 and 37% HCl was added.
The mixture was then stirred overnight at room temperature. The mixture was
subsequently poured into 100 mL of water and stirred for 1 hour. The solution was
extracted with methylene chloride (2×100 ml) and the organic layer was dried over
anhydrous sodium sulfate and evaporated on the rotavap to yield 0.8 g of product.
The NMR spectrum of the material was consistent with starting material.
Synthesis of 1,8-Dimethoxylanthracenedione
Dihydroanthraquinone (4 g, 16.65 mmol) and K2CO3 (5 g, 33.3 mmol) was
dissolved in 100 mL of acetone and Me2SO4 (3.5 mL, 33.3 mmol) was added and
stirred for 30 min at room temperature. The mixture was then refluxed for 20
hours. The solution was filtered and evaporated and the resulting solid was
washed with excess water. The product was purified by column chromatography
with methylene chloride as the mobile phase giving a yield of 3.71 g (83.07%),
(m.p. 210-2150C)
Synthesis of 1,8-Dimethoxyl-9-hydroxyanthracene (5)
1, 8-Dimethoxyanthracenedione (0.5 g, 1.87mmol) was suspended in glacial
acetic acid (50 mL). A solution of SnCl2 (4 g, 15.6 mmol) in HCl (15 mL) was
30

added in one portion and the suspension was stirred for 30 mins at room
temperature. The mixture was poured into water (500 mL) and stirred for
additional 10 mins. The organic portion was then extracted with methylene
chloride, and the extract was washed with water (3×100 mL), saturated NaHCO3
(2×100 mL), and rinsed with water (100 mL). The methylene chloride solution
was dried with sodium sulfate and purified by column chromatography to provide
0.1 g (20%) of product.
Synthesis of 2,2'-Anthracene-1,8-diylbis(1H-imidazole) (1)
1,8- Dimethoxylcarbonylanthracene (514.2 mg, 17.47 mmol) was added to
1.5mL of freshly distilled ethylenediamine. The reaction mixture was then
refluxed under nitrogen atmosphere for 8 hours. Excess ethylenediamine was
distilled under reduced pressure leaving a brownish solid. Several attempts were
made to characterize this product by NMR but all were unsuccessful as it was not
soluble in any of the common NMR solvents. The product was also insoluble in
hot phenyl ether and toluene and hence could not be used in subsequent oxidation
steps.
Synthesis of 2-(2’- Hydroxyphenyl)imidazole
Wintergreen oil (4.23 mL, 33 mmol) was dissolved in 3 molar excess of
ethylenediamine and the mixture was refluxed overnight under a stream of dry
31

nitrogen gas. The unreacted ethylenediamine was distilled under reduced pressure
and the resulting solid was washed with methylene chloride to remove trace
amounts of wintergreen oil and ethylenediamine. The remaining solid was then
recrystallized from 95% ethanol to obtain pale yellow crystals of 2-(2’hydroxylphenyl) -1H-imidazoline. (3.63 g, 67.2%, m.p. 190o – 195o)
The imidazoline (1.8 g, 11 mmol) was suspended in 12mL of phenylether
and heated until it dissolved. Palladium supported on carbon (Pd/C) (153.6 mg)
was added to the mixture while stirring and the mixture was refluxed for 5 hours.
The Pd/C catalyst was filtered and filtrate was loaded on a silica gel column and
eluted with benzene. The solid obtained was recrystallized from water. (900 mg,
50.64%, m.p. 131o – 133o, lit 133o – 134o) 10.
Synthesis of 2-Hydroxyisopthalic acid
Potassium hydroxide (120 g, 2.35 mol) was dissolved in 50 mL of water.
After the mixture cooled to room temperature, 3-methylsalicylic acid (20.00 g,
131.46 mmol) was added, and the slurry was stirred gently until all the acid
dissolved. Lead dioxide (120.00 g, 501.67 mmol) was then stirred and the mixture
was heated until the temperature reached 250oC. The mixture was kept at this
temperature for 15 minutes then cooled to room temperature. Water (250 mL) was
added to the mixture with stirring. The cold suspension was then filtered and the
32

solid was washed with 100 mL of water. The filtrate and washing were combined
and the mixture was partially acidified using HCl (35%, 80 mL). Sodium sulfide
was added to the mixture to precipitate any excess lead as PbS. The suspension
was brought to gentle boiling and then allowed to cool to coagulate the lead
sulfide, which was then filtered. The filtrate was cooled down to 10oC and
acidified with conc. HCl (90 mL) to precipitate the diacid. The diacid was filtered
out and recrystallized from water. (9.84 g, 47.33%, m.p. 238o – 240o)
Synthesis of Dimethyl-3-carboxysalicylate
2-Hydroxylisopthalic acid (5 g, 27.4 mmol) was dissolved in freshly distilled
methanol (75 mL) and 10 drops of concentrated sulfuric acid was added to the
mixture. The mixture was then refluxed for 6 hours. Excess methanol was
removed on the rotavap. The obtained solid was suspended in 5% NaHCO3
solution (150 mL) and extracted with methylene chloride. The methylene chloride
layer was dried over anhydrous sodium sulfate and evaporated to give the diester.
Recrystallization from ethylacetate – hexane mixtue provided fine white crystals of
the diester. (2.45 g, 57.63%, m.p.65o – 68o)
The NaHCO3 washing was acidified with HCl and the obtained solid was
filtered. The solid was dissolved in methylene chloride and chromatographed on a
silica gel column eluted with methylene chloride. The isolated mono-ester (233

hydroxy-3-(methoxycarbonyl)benzoic acid) was recrystallized from a mixture of
acetone-petroleum ether. (1.3 g, 40 %,m.p. 130o – 132o)
Synthesis of 2,6-Di(1H-imidazol-2-yl)phenol
Dimethyl-3-carboxysalicylate (500 mg, 2.37 mmol) was refluxed in 2 mL of
ethylenediamine overnight under nitrogen. Excess ethylenediamine was distilled
under vacuum. The residue was suspended in 12 mL of phenylether and 150 mg of
Pd/C was added and the mixture was refluxed for 7 hrs. The charcoal was filtered
and the product eluted from a silica gel column using a CH2Cl2/methanol mixture.
(90 mg, 16.78%, m.p.195oC – 200oC, 1HNMR (400MHz, CD3OD) δ 6.9 (1H, t), δ
7.2 (4H, s), δ 7.9 (2H, d) 13CNMR (100MHz, CD3OD) δ 116, 122, 126, 146, 154)
Synthesis of 2-Hydroxy-3-(1H-imidazol-2-yl)benzoic acid
2-Hydroxy-3-(methoxycarbonyl)benzoic acid (300 mg, 1.53 mmol) was
dissolved in 2mL of ethylenediamine and refluxed overnight under nitrogen.
Excess ethylenediamine was distilled under reduced pressure. Traces of
ethylenediamine were removed using a vacuum pump. The product obtained was
then suspended in 4mL of phenylether and 300 mg of Pd/C added to the mixture.
The mixture was then refluxed overnight and monitored by TLC. The product was
purified by silica gel column eluted with CH2Cl2/methanol mixture to give 30 mg
of product. (1HNMR (400 MHz, CDCl3, ppm) δ 6.83(1H, t), δ 7.04 (1H, d), δ 7.10
34

(2H, s), δ 7.22(t),δ 7.55 (1H, d) 13CNMR (100MHz, CDCl3, ppm) δ 113.50, 117.50,
118.50, 124.0, 130.50, 146.50, 157.00)
Synthesis of Methyl 2-({hydroxy[2-(1H-imidazol-2yl)phenoxy]phosphoryl}oxy)benzoate
Potassium salicylate (300 mg, 1.856 mmol) was dissolved in dry THF (15
mL) and PCl5 (386 mg, 1.856 mmol) was added to the reaction mixture. The
mixture stirred for 120 minutes under nitrogen. 2-(2’- Hydroxyphenyl)imidazole10
(300 mg, 1.856 mmol) was then added and the mixture was stirred for 120 more
minutes.Water (0.5 mL) was added to the mixture and THF was evaporated in the
hood. Saturated NaHCO3 (1 mL) was added followed by methanol (5 mL) and the
precipitate obtained was collected by filtration.
The above procedure was repeated in pyridine as solvent instead of THF.
The product was obtained as a sodium salt. (1HNMR (400MHz, DMSO, ppm)
δ3.70 (3H, s), δ 6.9(1H, t),δ 6.9(1H, d), δ 7.05(1H, t), δ 7.20(2H, s), δ 7.40 (1H, t),
δ 7.55 (2H), δ 7.85(1H, d))
Synthesis of N-(2-aminoethyl)-3-{2-[(2-aminoethyl)amino]-2-oxoethyl}2-hydroxybenzamide
Dimethyl-3-carboxysalicylate (1.5 g, 7.19 mmol) was dissolved in
acetonitrile (15 mL). Ethylenediamine (1.0 mL) was added and the mixture was
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refluxed until product precipitated out completely. The product was filtered and
dried in vacuo. (m.p. 180o – 183o), ( 1HNMR (400 MHz, CD3OD) δ8.0 (2H, d), δ
6.50 (1H, t), δ5.0 (4H, s), δ 3.6 (4H, t), δ 3.00 (4H, t), 13CNMR (100MHz, CD3OD)
δ 170.0, 134.0, 120.0, 112.0, 40.0, 38.0)
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CHAPTER 3
RESULTS AND DISCUSSION
Synthesis of Compounds in Model System 3
Synthesis of 2,6-Di(1H-imidazol-2-yl)phenol(17)
2,6-Di(1H-imidazol-2-yl)phenol was obtained as pale yellow solid from the
synthetic pathway proposed in Scheme 4. The initial step involved the synthesis of
dimethyl-3-carboxysalicylate (16) from 3- methylsalicylic acid (13) shown in
Scheme 3. The scheme involves the oxidation of the methyl group of (13) using
PbO2 under high temperature followed by the esterification of the resulting diacid
(14) yielding the diester (16) as the major product and the monoester (15) as a
minor product11. (Scheme 3)

Scheme 3. Synthesis of the esters 15 & 16
The next step in the synthesis involves a reaction between the diester (16)
and ethylenediamine to yield an imidazoline that is subsequently oxidized in the
presence of Pd/C10 at very high temperatures to the imidazole (17). (Scheme 4)
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Scheme 4. Synthesis of 2,6-di(1H-imidazol-2-yl)phenol(17)
2,6-Di(1H-imidazol-2-yl)phenol (17) was purified by column
chromatography using 5% methanol / CH2Cl2mixture. The yield was very low
(~16%). The structure of the compound was confirmed using NMR. The proton
NMR showed three peaks; a doublet and triplet at δ7.9 and δ6.9 ppm respectively
corresponding to aromatic protons of the benzene ring and a singlet at δ 7.2 ppm
corresponding to the imidazole proton. To further correlate the proton NMR to
structure, the integration of the individual peaks was calculated. The singlet
corresponding to the imidazole showed 4 times the value for the triplet that
corresponds to a single proton on the benzene ring. The doublet was twice as
intense as the triplet corresponding to the other two protons on the ring that are
equivalent. The 13C NMR showed 6 peaks in the aromatic region (δ110-160 ppm)
that corresponded to 5 pairs of equivalent carbons (2 pairs have same chemical
shift) and 2 unequivalent carbons thus further confirming the structure.
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Even though the NMR techniques confirmed the structure of 17, the overall
synthetic pathway is inefficient due to the resulting low yield. The low yield is
thought to come about as a combined effect of insolubility and catalyst poisoning.
During the reaction after the ethylenediamine has been distilled, the resulting
product was observed to be thick brownish viscous oil that was insoluble in both
cold and hot phenyl ether. When the Pd/C was added to the solution, it was
observed to stick to the oil and settle at the bottom of the reaction flask rendering it
inactive. Other dehydrogenation procedures found in literature12 were attempted,
but all failed due to similar solubility issues.
An alternative synthetic pathway was adopted via the formation of the
diamide. (Scheme 5)

Scheme 5. Alternative proposed pathway for synthesis of 17
In this pathway, the synthesis of compound 17 from the diamide was attempted in
different solvents. The diamide (18) was insoluble in all attempted solvents except
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DMSO13. The initial reaction is a dehydration reaction that should result in ring
formation giving the imidazoline product. The following oxidation step of
imidazoline to imidazole resulted in total decomposition to intractable product.
Synthesis of 2-Hydroxy-3-(1H-imidazol-2-yl)benzoic Acid(19)
2-Hydroxy-3-(methoxycarbonyl)benzoic acid (15) was isolated as a side
product. Based on knowledge of the catalytic importance of both the –COOH
group and the imidazole group, 2-hydroxy-3-(1H-imidazol-2-yl)benzoic acid
would be a very interesting compound to study. It was also thought it would pose
less solubility issues compared to previous models. A synthetic scheme (Scheme
6) was used based on literature procedures and methods already discussed earlier.

Scheme 6. Scheme for the synthesis of 2-hydroxy-3-(1H-imidazol-2-yl)benzoic
acid (19)
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The imidazole was eluted from a silica gel column using methanol/CH2Cl2
solvent system. Proton NMR showed the imidazole peak as a singlet at δ7.1ppm
and two doublets and a triplet at δ7.55, δ7.05, and δ6.85 ppm respectively. A
triplet observed at δ7.20 ppm is associated with impurities that could not be
removed by column chromatography. A controversy arose from the 13C NMR
where only 7 peaks were observed instead of 9 peaks. Thus structure could not be
accurately confirmed by NMR data.
Interestingly, when the monoester, 2-hydroxy-3-(methoxycarbonyl)benzoic
acid (15) was allowed to stand in open atmosphere at room temperature, it was
found to undergo complete auto hydrolysis in 48 hours as confirmed by TLC and
NMR.
The auto hydrolysis of 15 is thought to be a nucleophilic general base
assisted mechanism (Scheme 7). The initial step of the mechanism is the
formation of the alkoxide nucleophile, a strong nucleophile. The alkoxide ion
formed deprotonates a water molecule to form the OH – ion, which subsequently
attacks the ester to form the tetrahedral intermediate. The intermediate being
unstable breaks down to the diacid and the methoxide ion.
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Scheme 7. Proposed mechanism for hydrolysis of 2-hydroxy-3(methoxycarbonyl)benzoic acid (15)
Synthesis of Methyl 2-({hydroxy[2-(1H-imidazol-2yl)phenoxy]phosphoryl}oxy)benzoate (21)
2-(2’- Hydroxyphenyl)imidazole10 was synthesized (Scheme 8),
characterized, and used to confirm the structure of the imidazole group of the other
synthesized compounds. Based on a similar compound reported in literature1,
attempts were made to synthesize methyl 2-({hydroxy[2-(1H-imidazol-2yl)phenoxy]phosphoryl}oxy)benzoate (21) (Scheme 9).
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2-(2’- Hydroxyphenyl)imidazole was synthesized based on procedure
outlined by Thomas C. Bruice10 (Scheme 8).

Scheme 8. Scheme for the synthesis of 2 – (2’-hydroxyphenyl)imidazole
The initial attempt to carry out a reaction between salicylic acid and the imidazole
was unsuccessful. The acid functional group of salicylic acid was then protected
by a methyl ester. The potassium salt of wintergreen oil was then used and reacted
with the 2 – (2’-hydroxyphenyl)imidazole to form the compound 21 in very low
yield (Scheme 9). Compound 21 was isolated and NMR spectra obtained in
DMSO were consistent with the assigned structure.
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Scheme 9. Synthesis of methyl 2-({hydroxy[2-(1H-imidazol-2yl)phenoxy]phosphoryl}oxy)benzoate (21)
Synthesis of Anthracene – Based Compounds for Model Systems 1 and 2
(Scheme 2)
Two synthetic routes (Scheme 10) were attempted for the synthesis of 9 –
anthylphosphate (4). The first route involved the formation and isolation of the
alcohol (23)14 and the later reaction of compound (23) with POCl3 to form the
phosphate. This route was flawed in that the alcohol rapidly oxidizes to the
anthrone (starting material) under atmospheric conditions hence we were unable to
isolate the alcohol. Facing this difficulty, we decided to attempt to synthesize the
phosphate in situ without isolating the alcohol. After carrying out the reaction as
presented in Scheme 10, we were only able to isolate the starting material. A
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plausible explanation for this is that the conversion of the alcohol (23) to anthrone
is faster than the reaction between the alcohol and POCl3.

Scheme 10. Synthetic scheme used for 9 – anthylphosphate (4)
In an attempt to circumvent this problem, we modified our substrate from
compound 4 to compound 5 (Scheme 2). To synthesize compound 5, we needed to
synthesize 1, 8 – dimethoxy- 9- hydroxyanthracene15 (26) as an important
intermediate compound (Scheme 11).
Despite the similarities of compound 23 (Scheme 10) to compound 26, the
latter was synthesized successfully. This was possible because the alcohol
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function formed was stabilized through intramolecular hydrogen bonds (Figure 7)
as opposed to compound 23 that had no such stability factor. Compound 26 was
isolated in good yield and purified by silica gel column chromatography.

Scheme 11. Synthetic scheme for model compound 5

46

Figure 7. Hydrogen bond stabilization of 1, 8 – dimethoxy- 9- hydroxyanthracene
(26)
Scheme 10 was adopted to synthesize enzyme models 1 and 2. These
compounds are expected to recognize substrates such as compounds 4 and 5 by π –
π stacking. Such interaction would bring the catalytic groups in close proximity to
the phosphate ester leading to catalysis either by general acid – base, nucleophilic,
or a combination of both.

Scheme 12. Scheme for synthesis of 2,2'-anthracene-1,8-diylbis-1H-imidazole (1)
Anthracene-1, 8-dicarboxylic acid, compound 2 was synthesized according
to literature16. It was isolated in good yield and its data consistent with literature.
Synthesis of compound 1 from compound 2 as shown in Scheme 12 is presumably
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involving an imidazoline intermediate through reaction with ethylenediamine. The
reaction gave a product that we were unable to adequately characterize and confirm
it as the imidazoline intermediate due to solubility problems. The synthesis was
however continued based on the assumption that the product was the imidazoline.
Oxidation over Pd/C gave a product that was insoluble in all common solvent, and
was not pursued any further.
Conclusion
2,6-Di(1H-imidazol-2-yl)phenol has been successfully prepared by a twostep pathway involving reaction of ethylenediamine and dimethyl-3carboxysalicylate followed by dehydrogenation (oxidation) of the imidazoline
intermediate to the imidazole. The yield was low, about 16 %. Other
dehydrogenation aromatization reactions 12, 17,13 were attempted to improve the
yield but were unsuccessful despite their reported successes for similar reactions.
Another synthetic pathway involving the diamide intermediate was attempted but
failed due to solubility problems. Similarly, all attempts to synthesize 2,2’anthracene-1,8-diylbis-1H-imidazole were unsuccessful.
Throughout all attempted synthetic pathways to obtain the imidazole – based
model compounds, the imidazoline intermediate could not be isolated and
confirmed. Syntheses were continued based on the assumption that the
imidazoline intermediates were formed. Oxidative aromatization reactions of
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imidazolines10, 12, 17 have been reported in literature. We believe that in order to
improve the yield of the desired imidazole products, major improvement in the
synthesis of the imidazoline intermediates are needed.
Synthesis of methyl 2-({hydroxy[2-(1H-imidazol-2yl)phenoxy]phosphoryl}oxy)benzoate was accomplish although in low yield.
After initial attempts failed, it was realized that the order of addition of the
reactants is very important and that converting the phenols to their salts makes
synthesis easier. The phenolate salts are more basic and more nucleophilic than
neutral phenols and thus more reactive with phosphorus pentachloride. We thus
recommend the use of the salts of all phenols in the synthesis of methy- 2({hydroxy[2-(1H-imidazol-2-yl)phenoxy]phosphoryl}oxy)benzoate.
The mono ester, 2-hydroxy-3-(methoxycarbonyl)benzoic acid was found to
undergo auto hydrolysis to produce 2-hydroxylisopthalic acid when exposed to
open atmosphere. A nucleophilic, general base assisted mechanism was proposed
for the hydrolysis process. Further studies will follow to verify the proposed
mechanism for this hydrolysis reaction.
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APPENDICES
Appendix A 1HNMR of 2 – (2’-hydroxyphenyl)imidazole in CDCl3
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Appendix B 13CNMR of 2 – (2’-hydroxyphenyl)imidazole in CDCl3
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Appendix C 1H NMR of 2-hydroxyisophthalic acid (14) in acetone – d6
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Appendix D 13C NMR of 2 – hydroxyisophthalic acid (14) in acetone - d6
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Appendix E 1H NMR of dimethyl-3-carboxylsalicylate (16) in CDCl3
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Appendix F 13C NMR of dimethyl-3-carboxylsalicylate (16) in CDCl3
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Appendix G 1H NMR of 2,6-di(1H-imidazol-2-yl)phenol (17) in CD3OD
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Appendix H 13C NMR of 2,6-di(1H-imidazol-2-yl)phenol (17) in CD3OD
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Appendix I 1H NMR of 2-hydroxy-3-(1H-imidazol-2-yl)benzoic acid (19) in
CDCl3

62

Appendix J 13C NMR of 2-hydroxy-3-(1H-imidazol-2-yl)benzoic acid (19) in
CDCl3
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Appendix K 1H NMR of Compound 18 in CD3OD
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Appendix L 13C NMR of Compound 18 in CD3OD
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Appendix M 1H NMR of methyl 2-({hydroxy[2-(1H-imidazol-2yl)phenoxy]phosphoryl}oxy)benzoate (21) in DMSO-d3
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Appendix N 1H NMR of 2-(2’-hydroxylphenyl) -1H-imidazoline in D2O
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Appendix O 1H NMR of 1,8-dimethoxylanthracedione (25) in CDCl3
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Appendix P 13C NMR of 1,8-dimethoxylanthracedione (25) in CDCl3
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Appendix Q 1H NMR of 1, 8 – dimethoxy- 9- hydroxyanthracene (26) in CDCl3

70

Appendix R 1H NMR of anthraquinone-1,8- dicarboxylic acid (29) in
acetone-d6
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Appendix S 13C NMR of anthraquinone-1,8- dicarboxylic acid (29) in
acetone-d6
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Appendix T 1H NMR of product obtained from converting anthrone to 9-anthranol
(23) in CDCl3
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Appendix U 13C NMR of product obtained from converting anthrone to 9anthranol (23) in CDCl3
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